January 8, 2021
Editor's note: This story has been updated with additional information and quotes from Hinge Health.
Hinge Health, a San Francisco company tackling musculoskeletal (MSK) health through digital programs with live virtual sessions, has wrapped up a $300 million Series D round that places its total value at $3 billion, according to a recent announcement.
The "heavily oversubscribed" round was led by...
February 4, 2020
Hinge Health, the maker of digital programs for chronic musculoskeletal (MSK) health, has closed $90 million in a new round led by Bessemer Venture Partners. Lead Edge Capital also took part in the Series C, as did prior backers Insight Partners, Atomico, 11.2 Capital, Quadrille Capital and Heuristic Capital.
Hinge had been courting investors throughout the course of the last quarter, and...
September 18, 2019
Virtual reality pain management company Karuna Labs has raised $3 million in seed funding, the San Francisco startup announced last week. The funding was led by Baseline Ventures, with additional participation from Anorak Ventures, the AET Fund, the Hustle Fund, Correlation Ventures and Dreamit Ventures.
WHAT THEY DO
The company develops personalized VR programs for chronic pain management. The...
January 15, 2019
A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by employees of the company, was published last week in npj Digital Medicine.
Hinge Health’s digital care program (DCP) is designed for numerous musculoskeletal conditions, and consists of app-based...
February 22, 2018
As opioid abuse continues to make impact in the US, more and more tech-driven answers to the drug crisis are springing up that aim to reduce patients’ reliance on prescription opioids. Just yesterday, behavioral health therapy app maker 2Morrow threw its hat into the ring with the announcement that its services now include a digital chronic pain management program.
Much like the company’s other...
September 18, 2017
Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet.
The Intellis system is designed to treat chronic pain by delivering neurostimulation at the spinal cord. Using a Samsung Galaxy Tab S2, the patient's caregiver can adjust the neurostimulation according to a workflow designed by Medtronic called Evolve.